The Valley Desk

NCT01677455 · Interventional trial

An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer

Overall registry status Completed

Phase 2

Conditions Breast Cancer, ER/Progressive Response (PR) + Refractory to Prior Hormonal Treatment, HER-2 Positive Breast Cancer, Triple Negative Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov